Ad is loading...
MASOX
Price
$11.74
Change
+$0.19 (+1.65%)
Updated
Nov 22 closing price
VSMAX
Price
$123.45
Change
+$1.87 (+1.54%)
Updated
Nov 22 closing price
Ad is loading...

MASOX vs VSMAX

Header iconMASOX vs VSMAX Comparison
Open Charts MASOX vs VSMAXBanner chart's image
MoA Small Cap Equity Index Fund
Price$11.74
Change+$0.19 (+1.65%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index
Price$123.45
Change+$1.87 (+1.54%)
VolumeN/A
CapitalizationN/A
MASOX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MASOX vs. VSMAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MASOX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 151B vs. MASOX (224M). MASOX (1.44) and VSMAX (1.42) have matching dividends . MASOX was incepted earlier than VSMAX: MASOX (6 years) vs VSMAX (24 years). MASOX is a more actively managed with annual turnover of: 43.99 vs. VSMAX (12.00). MASOX (3000) and VSMAX (3000) have matching initial minimum investment requirements. VSMAX annual gain was more profitable for investors over the last year : 34.52 vs. MASOX (29.39). VSMAX return over 5 years is better than : 63.57 vs. MASOX (31.07).
MASOXVSMAXMASOX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD15.76421.10075%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets224M151B0%
Annual Yield % from dividends1.441.42101%
Returns for 1 year29.3934.5285%
Returns for 3 years-11.0212.56-88%
Returns for 5 years31.0763.5749%
Returns for 10 yearsN/A130.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOPE166.454.32
+2.66%
Grand Canyon Education
MPWR580.818.34
+1.46%
Monolithic Power Systems
CIM14.660.04
+0.27%
Chimera Investment Corp
INKT0.68-0.01
-1.46%
MiNK Therapeutics
ME3.11-0.12
-3.72%
23andMe Holding Co